Midhasso Foge, PHARMD
Pharmacist in Tehachapi, California. This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers — including 290,447 in Pharmacist, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration — see our methodology.
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Midhasso Foge, PHARMD filed 487 Medicare Part D claims in 2023 as a Pharmacist in Tehachapi, California, prescribing 44% generic.
- 487
- Part D claims, 2023
- 44%
- generic prescribing
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
Midhasso Foge, PHARMD's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023 — across all CMS prescribers nationally
487 Top 38% higher than 62% of 1,370,886 prescribers
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Medicare Part D Prescriber Public Use File · 2023
What does the federal data show about Midhasso Foge, PHARMD?
Quality data not reportedPrimary specialty
Medicare Part D claims
Specialty distribution in California
How Pharmacist compares to other specialties among California providers
Largest specialties in California (% of in-state providers)
Pharmacist ranks #5 among California's specialties (3.5% of in-state providers)
Each bar is a specialty's share of the California provider total, by primary NUCC taxonomy. The highlighted bar is Pharmacist; the long tail of smaller specialties is omitted for legibility.
Specialty board-certification context
Estimated specialty board-certified rate — Pharmacist (ABMS / AOA reference)
- Est. board-certified rate
- 78%
- Pharmacist ABMS/AOA estimate
Est. board-certified rate (Pharmacist) — ABMS / AOA estimate
Verify credentials
- Verify via ABMS free public lookup
- Verify via AOA osteopathic boards
- Specialty volume Pharmacist US NPIs
Specialty board-certified rate — Pharmacist estimate
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus Maintenance of Certification cycles. CMS does not publish a per-provider board-certification field; the figure shown is the specialty-level estimated rate from ABMS / AOA reference data.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Midhasso Foge, PHARMD appears in the CMS NPPES registry as a Pharmacist provider holding PHARMD credentials at 22721 WOODFORD TEHACHAPI RD, Tehachapi, CA, 93561, with a listed phone of (763) 439-6526. NPI 1104195510 was issued on 12/14/2011. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what Foge most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 487 prescription claims written by this provider, covering 71 Medicare beneficiaries and totaling roughly $167K in drug spend, split 44% brand-name and 44% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.
Pharmacist is a high-volume specialty nationwide, with 290,447 enrolled providers across 56 states and an average of 135 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1104195510 |
|---|---|
| Specialty | Pharmacist |
| Credentials | PHARMD |
| Gender | Male |
| NPI Issued | 12/14/2011 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Midhasso Foge, PHARMD's current license status, disciplinary history, and board certifications with the Medical Board of California in California before relying on this page for a clinical or care decision.
How we sourced this profile
License & disciplinary context — California MBC 2023 annual report
Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to Midhasso Foge, PHARMD. To verify Midhasso Foge, PHARMD's current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Above average
44% brand-name claims vs 44% generic, on 487 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 1,065
- Total Day Supply
- 31,746
- Brand vs Generic
- 44% brand / 44% generic
- Brand Drug Cost
- $157K
- Generic Drug Cost
- $6K
Patient Demographics
- Average Patient Age
- 65.6 years
- Avg HCC Risk Score
- 1.15
- Gender Split
- 72% female / 28% male
- Age Distribution
- <65: 19, 65-74: 44, 75-84: N/A, 85+: N/A
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Midhasso Foge, PHARMD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Ozempic
Ozempic
56 claims
- Novolog Flexpen
Novolog Flexpen
44 claims
- Metformin Hcl
Metformin Hcl
40 claims
- Glimepiride
Glimepiride
27 claims
- Jardiance
Jardiance
25 claims
- Warfarin Sodium
Warfarin Sodium
25 claims
- Pioglitazone Hcl 21
Pioglitazone Hcl
21 claims
- Atorvastatin Calcium 19
Atorvastatin Calcium
19 claims
| Drug | Claims |
|---|---|
| Ozempic Semaglutide | 56 |
| Novolog Flexpen Insulin Aspart | 44 |
| Metformin Hcl | 40 |
| Glimepiride | 27 |
| Jardiance Empagliflozin | 25 |
| Warfarin Sodium | 25 |
| Pioglitazone Hcl | 21 |
| Atorvastatin Calcium | 19 |
| Glipizide | 12 |
| Eliquis Apixaban | 11 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Pharmacist Overview
How Midhasso Foge, PHARMD fits within the Pharmacist landscape nationally.
Midhasso Foge, PHARMD's 487 claims are above the specialty average of 135.
Nearby Pharmacist Providers in California
Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as Foge.
Compare Pharmacist nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry — providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the California medical board — federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Pharmacist peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only — they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore California
Frequently Asked Questions
What is Midhasso Foge, PHARMD's specialty? ▼
How much does Midhasso Foge, PHARMD prescribe under Medicare Part D? ▼
Where is Midhasso Foge, PHARMD located? ▼
What is Midhasso Foge, PHARMD's NPI number? ▼
Does Midhasso Foge, PHARMD prescribe more brand-name or generic drugs? ▼
How many Pharmacist providers are there in the US? ▼
What drugs does Midhasso Foge, PHARMD prescribe most often? ▼
Does Midhasso Foge, PHARMD accept Medicare? ▼
How can I verify Midhasso Foge, PHARMD's credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology